Insiders · Profile

Maher Bill

Director at abrdn Life Sciences Investors · Director at abrdn Emerging Markets ex-China Fund · Director at abrdn World Healthcare Fund · and 2 more. Filing since 19 Apr 2021. CIK 0001289076

HQL abrdn Life Sciences Investors Director · 2 trades AEF abrdn Emerging Markets ex-China Fund, Inc. Director · 5 trades THW abrdn World Healthcare Fund Director · 1 trade THQ abrdn Healthcare Opportunities Fund Director · 1 trade HQH abrdn Healthcare Investors Director · 1 trade

Company

Date

Role

Action

Shares

Amount

Of holding

HQL abrdn Life Sciences Investors

23 Aug 2024

Director

Bought

650

$9.99K

61.0%

AEF abrdn Emerging Markets ex-China Fund, Inc.

23 Aug 2024

Director

Bought

931

$5.00K

6.6%

THW abrdn World Healthcare Fund

14 Aug 2024

Director

Bought

1,000

$13.03K

opened

AEF abrdn Emerging Markets ex-China Fund, Inc.

14 Aug 2024

Director

Bought

1,000

$5.25K

7.7%

THQ abrdn Healthcare Opportunities Fund

28 Dec 2023

Director

Bought

1,000

$18.25K

opened

HQH abrdn Healthcare Investors

28 Dec 2023

Director

Bought

1,000

$16.58K

opened

HQL abrdn Life Sciences Investors

28 Dec 2023

Director

Bought

1,000

$13.57K

opened

AEF abrdn Emerging Markets ex-China Fund, Inc.

22 Apr 2021

Director

Bought

7,000

$60.14K

131%

AEF abrdn Emerging Markets ex-China Fund, Inc.

20 Apr 2021

Director

Sold, plan not stated

7,000

$60.13K

56.7%

AEF abrdn Emerging Markets ex-China Fund, Inc.

19 Apr 2021

Director

Bought

7,000

$60.74K

131%

10 decisions on file.